Bruland ØS, Larsen RH, Baum RP, Juzeniene A(2023) Editorial: Targeted alpha particle therapy in oncology Front Med (Lausanne), 10, 1165747 DOI 10.3389/fmed.2023.1165747, PubMed 36960341
Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE(2023) Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study Int J Epidemiol, 52(3), 887-898 DOI 10.1093/ije/dyac223, PubMed 36413027
Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH(2023) Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach Front Med (Lausanne), 9, 1051825 DOI 10.3389/fmed.2022.1051825, PubMed 36733936
